Views & Analysis

The Evolution of Scenario Planning and Simulation to Address Modern Market and Landscape Challenges

Introduction Having worked in the field of future decision making and strategy for many years our team have

The Evolution of Scenario Planning and Simulation to Address Modern Market and Landscape Challenges

https://pharmaphorum.com/views-analysis-sales-marketing/the-evolution-of-scenario-planning-and-simulation-to-address-modern-market-and-landscape-challenges/

Building a new type of pharmaceutical company – a vision for pharma 2.0

The definition of healthcare has become incredibly diverse since the turn of the century. It feels like it

Building a new type of pharmaceutical company – a vision for pharma 2.0

https://pharmaphorum.com/views-analysis-sales-marketing/building-new-pharmaceutical-company-pharma-2-0/

Getting inspired at South by Southwest

Following this year’s South by Southwest (SXSW) conference in Austin, Texas, it occurred to me that the progression

Getting inspired at South by Southwest

https://pharmaphorum.com/views-analysis-sales-marketing/getting-inspired-at-south-by-southwest/

eyeforpharma barcelona day three

Day three: Thursday 14 March Highlights include: Keynote addresses from Kris Sterkens, company groups chairman EMEA at Janssen,

eyeforpharma barcelona day three

https://pharmaphorum.com/views-and-analysis/eyeforpharma-barcelona-day-three/

eyeforpharma barcelona day two

Day two: Wednesday 13 March Highlights include: John Zibert, chief medical officer of LEO Innovation Lab, on being

eyeforpharma barcelona day two

https://pharmaphorum.com/views-and-analysis/eyeforpharma-barcelona-day-two/

eyeforpharma Barcelona day one

Day one: Tuesday 12 March Highlights include: Brent Saunders, CEO of Allergan, discusses the biggest challenges for the

eyeforpharma Barcelona day one

https://pharmaphorum.com/event-coverage/eyeforpharma-barcelona-2019-day-1/

Reducing the burden on medical signatories

The ABPI Code of Practice has always included strict requirements for the certification of promotional and some non-promotional activities and materials. The Prescription

Reducing the burden on medical signatories

https://pharmaphorum.com/views-and-analysis/reducing-the-burden-on-medical-signatories/

Q4 results roundup 2019

With the full year results season drawing to a close, Richard Staines asks who the winners were and

Q4 results roundup 2019

https://pharmaphorum.com/sales-marketing/q4-results-roundup-2019/

Let’s talk about drugs

Paul Tunnah asks if we need to rethink pharma’s strict marketing regulations and have a discussion on how

Let’s talk about drugs

https://pharmaphorum.com/views-and-analysis/lets-talk-drugs/

1 2 3 4 5 >»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Search

Advanced Search

Trending

Views & Analysis